Adaptive Biotechnologies, which is working with Microsoft and Amgen to fight COVID-19 using its technology for sequencing the human immune system, reported a 65% increase in first quarter revenue, to… Read More
Despite a potential vaccine, the novel coronavirus could return on a seasonal basis, much like the flu, according to Seattle-based company Adaptive Biotechnologies. That’s one of the reasons Adaptive is… Read More
Biotech giant Amgen is putting up the money to fund three research projects in partnership with the University of Washington’s Institute for Protein Design (IPD). Amgen declined to disclose the… Read More
Alder BioPharmaceuticals has raised $170 million in a stock offering and is ramping up operations after filing an FDA application for eptinezumab, a therapy for patients with chronic migraines. Alder… Read More
Expedia isn’t coming to Seattle until 2019, but crews have already begun demolishing old lab space at the company’s future 40-acre Seattle waterfront campus. Last year Expedia announced it was re-locating its headquarters from… Read More
Seattle-based Just Biotherapeutics said Monday it closed a $14 million funding round led by the Bill & Melinda Gates Foundation. A group of former Amgen scientists founded Just in 2014. The… Read More
Nearly a year ago, Mark Nagle was on the hunt for a location that could serve as Expedia’s new headquarters. He found himself standing outside one spring afternoon on a sprawling campus along the Seattle… Read More
Expedia says it won’t be making its much-anticipated move to Seattle until 2019, a development that gives the company a little more time to deal with all the logistical headaches that come with… Read More
Expedia is pulling back the curtain on its long-term vision for the 40-acre site the company bought for its new Seattle headquarters in April. PREVIOUSLY: Expedia lays groundwork for giant expansion of… Read More
Expedia’s new waterfront headquarters in Seattle could one day grow into a 1.6 million-square-foot campus, according to transit planning documents obtained by GeekWire. FOLLOW-UP: Inside Expedia’s expansion plans: New Seattle campus could… Read More
Here’s another dose of bad news for Seattle’s biotech industry. Novo Nordisk this week announced plans to discontinue R&D efforts related to inflammatory disorders, a move that will cost about… Read More
Amgen dealt a blow to Seattle’s biotech industry last week with the announcement that it will be closing its large research-and-development campus on Elliott Bay, which dates back to its acquisition of… Read More
For anyone interested in having meals delivered to the home or office, there’s a smorgasbord of new options these days — a cornucopia of services and apps competing to provide your next… Read More
News that Amgen plans to shutter its 40-acre campus along Elliott Bay marks yet another setback for Seattle’s biotech industry, which has struggled to take root over the years. Amgen… Read More
Biotech giant Amgen says it will close its facilities in the Seattle region — including its 40-acre waterfront campus on Elliott Bay, inherited with its acquisition of Immunex more than a decade ago.… Read More